Lentivectors and plasmids. SparQ
TM cumate switch inducible expression constructs, pCDH-EF1-CymR-T2A-Puro (QM200PA-2), pCDH-CuO-MCS-EF1-GFP dual promoter lentivector (QM511B-1), and customized construct pCDH-CuO-miR126-EF1-GFP were purchased from System Biosciences (SBI). pMIR-REPORT TM miRNA expression reporter (AM5795) and pcDNA TM 3.1(+) vector (V790-20) were from Invitrogen. cd97
3'-UTR was amplified from human genomic DNA using the following primers: AAT TAA CTA GTA GGC GCA TGG TTC TGG ACG GCC CAG (forward) and ATT TTT CAG TGT TGA CAC TTA AAA TTA AAC ACA TGC ATA CAG AAG AAA GCT TTA TA (reverse).
Lentiviral transduction. MDA-CymR cells stably expressing pCDH-EF1-CymR-T2A-
Puro were generated by transducing MDA-MB-231 breast cancer cells (ATCC) with pCDH-EF1-CymR-T2A-Puro virus (SBI, QM200VA-2) followed by a 14-day selection with 10 µg/mL puromycin. To produce lentivirus containing inducible miR-126 constructs, HEK 293FT cells (Invitrogen) at 80% confluency were transiently transfected with either pCDH-CuO-miR126-EF1-GFP or pCDH-CuO-MCS-EF1-GFP using was calculated using the ∆∆Ct method as previously described. 
Enrichment of newly synthesized proteins. After incubation with Aha for 4 h, cells
were washed, detached, and lysed using cold 4% SDS/PBS solution containing protease inhibitors (Roche). Lysates were clarified by centrifugation at 14,000 g for 5 min.
Supernatant was collected and diluted to a final SDS concentration of 0.1%. Total protein concentration in each lysate sample was quantified using a BCA protein assay according to the manufacturer's protocol (Pierce) . Lysates from light and heavy cultures were mixed at equal protein concentration. Affinity probes were attached using published conditions. 3 Excess probes were removed by precipitating proteins with cold acetone at -20 °C.
To enrich for newly synthesized proteins, pelleted protein was dissolved in 0.1% SDS/PBS solution and allowed to bind Streptavidin Plus UltraLink resin (Pierce) for 1 h at RT. Samples were washed thoroughly with 1% SDS/PBS and 0.1% SDS/PBS and bound proteins were cleaved by incubation with 5% formic acid for 4 h. Newly synthesized proteins were then eluted with 0.1% SDS/PBS and concentrated for further preparation for MS.
Sample preparation for MS. Enriched proteins were separated by SDS-PAGE and each lane of the gel was cut into eight equal slices. Gel slices containing proteins were subjected to reduction with 7 mM DTT solution for 30 min at 50 °C before alkylation with 37 mM chloroacetamide for 30 min in the dark. In-gel digestion was carried out in 3 ng/µL LysC (Promega) solution at 37 °C overnight. Peptides were extracted from gel slices and desalted on C 18 columns prior to MS analysis.
Mass spectrometry.
Mass spectrometry experiments were performed on an EASY-nLC however, MaxQuant calculates tighter individual precursor tolerances after recalibration.
Fragment ion tolerance was 0.5 Daltons. Peptide, protein, and site false discovery rates were fixed at 1% using the target-decoy approach with a reversed database. 4 The minimum number of peptides for quantification was 1. Further data processing was performed to calculate ratios and standard errors of the ratios using in-house scripts described previously. 5 Briefly, hierarchical models are constructed of the data, where the overall ratio for each protein is the geometric mean of the biological replicates and the biological replicate ratio is the median of all of the peptide ratios in the replicate. The standard error of the overall protein ratio is calculated by estimating the global peptide 7 ratio standard error using pooled variance (calculated separately for peptide ratios based on requantified isotopic patterns) and using a bootstrapping procedure to resample at each level in the hierarchical model. Raw files are downloadable on Chorus.
Luciferase reporter assays. HEK293 cells (20,000 per well) were seeded in a 96-well plate and grown for 24 h. Cells were transfected with a plasmid cocktail containing 50 ng pRL-CMV (renilla luciferase control), 50 ng firefly luciferase construct outfitted with the 3'-UTR of interest, and either pcDNA expression at various time points after induction with concentrations of cumate ranging from 0 to 600 µg/mL. To achieve both robust and physiologically relevant miR-126 expression, we induced with 300 µg/mL cumate for 24 h for proteomic studies. Table S1 . Proteins responsive to miR-126 over-expression were identified by a combined BONCAT-SILAC approach. Listed are proteins quantified by at least 6 independent peptide ratio measurements and exhibiting consistent up-or down-regulation by more than 20%. 
